Altimmune, Inc.Altimmune, Inc.Altimmune, Inc.

Altimmune, Inc.

No trades
See on Supercharts

Price target

326.770.000.00%
The 8 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALT1 EPS for the last quarter is −5.06 MXN despite the estimation of −6.31 MXN. In the next quarter EPS is expected to reach −4.99 MXN. Track more of Altimmune, Inc. financials and stay on top of what is up with the company.
In the next quarter Altimmune, Inc. revenue is expected to reach ‪26.20 K‬ MXN. Check out Altimmune, Inc. revenue and earnings and make informed decisions.
According to analysts, ALT1 price target is 326.77 MXN with a max estimate of 515.46 MXN and a min estimate of 18.41 MXN. Check if this forecast comes true in a year, meanwhile watch Altimmune, Inc. stock price chart and keep track of the current situation with ALT1 news and stock market news.
We've gathered opinions of 9 analysts rating ALT1 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.